![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
Gilead Sciences signs joint procurement agreement with the European Commission for Veklury (remdesivir)
Gilead Sciences and the EC signed a joint procurement agreement (JPA) that will enable rapid and equitable access to Veklury® (remdesivir), the first antiviral...
News
Regeneron’s REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing...
News
BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1
BryoLogyx, Inc., announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1 is the company’s...
Clinical Trials
Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the...
News
New Zealand signs deal with Pfizer, BioNTech for Covid-19 vaccine
The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany’s BioNTech, with delivery potentially...
News
Pistoia Alliance launches seed fund to drive biopharma and healthcare innovation
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, launched its new Innovation...
News
High Purity New England Introduces Defined Tubing Routing for Single-Use Facilities
High Purity New England (HPNE), a leading supplier of biopharma equipment and process systems for the Biopharma industry announces its new line of Defined...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read